研究業績
-
2024年01月04日A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
-
2024年01月04日No tumorigenicity of allogeneic induced pluripotent stem cells in major histocompatibility complex-matched Cynomolgus Macaques
-
2024年01月04日Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy
-
2024年01月04日Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human disease
-
2024年01月04日Capturing human trophoblast development with naive pluripotent stem cells in vitro
-
2024年01月04日Generation of highly proliferative, rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy
-
2024年01月04日The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-1derived iPS cells
-
2024年01月04日Induced pluripotent stem cell-derived natural killer cells gene-modified to express chimeric antigen receptor-targeting solid tumors
-
2024年01月04日iPS細胞を用いたがんに対する免疫療法
-
2024年01月04日Current status and future perspectives of HLA-edited induced pluripotent stem cells.
-
2024年01月04日Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response
-
2024年01月04日Podoplanin as an attractive target of CAR-T cell therapy.
